APPA QGM Apr 2017
4 April 2017
APPA Survey & Plans – MSL Excellence – Collaboration
4 April 2017
APPA Survey & Plans – MSL Excellence – Collaboration
30 March 2017
APPA Survey & Plans – MSL Excellence – Collaboration
Our first Melbourne meeting
13 December 2016
Theme – Biosimilars (What, Why, How, Where, When and Who)
21 July 2016
David Grainger, a Senior Director in the Global Public Policy group at Eli Lilly, will be speaking about the role of the patient in the PBAC/PBS process; Andrew Moore and Matt Martin from Interact Technology will be demonstrating our new member-only App (called APP-A); and Michelle Gallaher of The Social Science will discussing the emerging role of social media in pharma.
10 March 2016
Nick Lush, the Editor of Pharma in Focus, will be speaking about putting the media into medical – how can we move medical affairs forward together; and Dr. David Cade, Chief Medical Office of Sirtex, will talk about the sphere of responsibility of medical affairs within an Australian start-up.
3 December 2015
James Boyce – Director of Communications and Government Relations at Medicines Australia will speak about valuing the innovative medicines industry: a year of political challenges and the work ahead to change perceptions in Australia.
18 September 2015
Dr Saxon Smith – President, AMA (NSW) Board of Directors will be speaking about his passion for public health and patient advocacy. He will also provide a perspective on the AMA’s vision for modern Australian healthcare as well as discuss the role of the pharmaceutical industry in improving the lives of Australian patients.
11 June 2015
Tim James (CEO of Medicines Australia)
Medicines Australia and its Strategic Priorities
5 March 2015
Mendel Grobler (Director – Strategic Access and Policy, Pfizer)
The Pharmaceutical Benefits Scheme: Bent, overspent or just spent?
4 December 2014
Mr Peter Stephenson (Multichannel Marketing Manager @ MSD) will be speaking about how new digital technologies are reinventing healthcare as healthcare professionals and patients increasingly embrace digital technologies.
Annual General Meeting and election of APPA Committee.
20 August 2014
Geoff McDonald (General Manager, GSK) and Deborah Monk (Compliance Director, Medicines Australia) will be speaking about the revised Medicines Australia’s Code on Conduct, including Transparency and the reporting of payments to healthcare professionals.
22 May 2014
Ms. Catherine King, Shadow Health Minister, will be speaking on major issues in the federal health portfolio, specifically the Pharmaceutical Benefit Scheme; as well as responding to any proposed changes to health policy that may be announced in the May budget.